Skip to main content

Collaboration in ATMP Development

December 15, 2021

podcast

How important is collaboration in ATMP development? What can be done to expedite ATMP manufacturing and release?

Collaboration has been a huge part of the COVID-19 pandemic response, but it is also hugely important in the development of various other therapeutics. In the second episode in our advanced therapy medicinal products (ATMPs) series Jérôme Larghero, Director of the Department of Biotherapies and the MEARY Center for Cell and Gene Therapy in the Hôpital Saint-Louis, AP-HP, and Julien Textoris, Vice President of Global Medical Affairs, Immunoassays and host response at bioMérieux, discuss the importance of collaboration between academia and industry in the development of ATMPs.

Find out about all of this and more in this podcast:

ON THE SAME SUBJECT

BIOFIRE MYCOPLASMA

BIOFIRE® Mycoplasma Nucleic Acid Amplification Technique (NAT)

Fully Automated PCR-based Mycoplasma Detection Method

ENDONEXT

ENDONEXT™ Solutions

Better For Your Lab. Better For The Planet.

SCANRDI

SCANRDI®

Real-time Monitoring Tool for Fast Decision Making